GameStop Stock Surges As Roaring Kitty Launches Video Countdown: What Investors Should Know
The Roaring Kitty YouTube channel looks set to host its first livestream in years with a countdown set for June 7.
What’s Going On With AMC Entertainment, Koss Corp, BlackBerry And Newegg Shares Thursday?
Several meme stocks including AMC Entertainment Inc (NYSE:AMC), Koss Corp (NASDAQ:KOSS), BlackBerry Ltd (NYSE:BB) and Newegg Commerce Inc (NASDAQ:NEGG) are trading higher Thursday following a swift surge in GameStop Corp (NYSE:GME) stock. Here's what you need to know.
What’s Going On With Core Scientific Shares Thursday
Core Scientific, Inc. (NASDAQ: CORZ) shares are moving higher on Wednesday afternoon. The company announced the rejection of an unsolicited acquisition proposal from CoreWeave, which valued Core Scientific at $5.75 per share in cash.
Tesla Rival Rivian Rolls Out Next-Gen R1S And R1T: Enhanced Performance, Design, And Tech Start At $69,900
Rivian debuts upgraded R1S SUV and R1T pickup, boasting advanced performance and design, priced from $69,900, challenging Tesla's dominance.
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday’s session after the company reported worse-than-expected quarterly…
Why Cybersecurity Company SecureWorks Shares Are Seeing Blue Skies Today
SecureWorks reports strong Q1 FY25 results, with revenue of $85.652M, exceeding estimates. Adjusted EPS at $0.05 surpasses consensus.
Why Outdoor Equipment Products Provider Toro Shares Are Surging Today
Toro reported Q2 FY24 results, sales up 1%, beating consensus, adjusted EPS $1.40 (-11% Y/Y), FY24 outlook remains unchanged.
Bitcoin Mining Stock Iris Energy Is Trading Higher: What’s Going On?
Iris Energy Ltd (NASDAQ:IREN) stock is trading higher. The company on Thursday issued its monthly operations update.
Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released
4D Molecular Therapeutics shares interim data from the 4D-710 Phase 1/2 AEROW clinical trial for cystic fibrosis lung disease.
Halozyme Therapeutics +13% On Thursday: What’s Going On?
Halozyme Therapeutics surges as it raises FY24 guidance, driven by increased revenue projections and a new European patent for its drug delivery platform.